Bend, Ore.--Bend Research Inc., part of Capsugel's Dosage Form Solutions (DFS) business unit, announced today an investment of more than $20 million to expand commercial manufacturing for spray-dried ...

BEND, Ore., Aug. 30 /PRNewswire/ -- Bend Research Inc. (www.bendres.com), a leading independent drug-formulation development and manufacturing company, announced today that it has received a new U.S.

Significantly expands the commercial manufacturing capability at its Bend, Ore. site Morristown, N.J., June 30, 2015 – Capsugel, a global leader in delivering high-quality, innovative dosage forms and ...

Bend Research, a division of Capsugel Dosage Form Solutions, announced Monday that it has installed its first commercial-scale spray dryer in its research and development facility in Bend. The new ...

LISBON, Portugal, Jan. 12, 2021 /PRNewswire/ -- Hovione, the leader in Pharmaceutical Spray Drying, today announced the launch of ASD-HIPROS, a proprietary screening service for spray dried ...

Earlier this year, Hovione announced a partnership with a Danish firm that has developed a whey protein–based excipient meant to enhance spray-dry dispersions. Hovione saw in Zerion Pharma’s ...

Bend Research Inc., a leading independent drug-formulation development and manufacturing company, has entered into a licensing agreement with Eli Lilly and Company. Under the terms of the agreement, ...

A phase I study of 2-hydroxyoleic acid (2-OHOA), a novel sphingomyelin synthase activator in patients (pt) with advanced solid tumors (AST) including refractory high grade gliomas/glioblastomas (GBM): ...

The pharmaceutical company Capsugel, parent company of Bend Research, today celebrated the completion of new commercial manufacturing facility in Bend. The new 5,872-square-foot building at 20503 ...

(MENAFN- EIN Presswire) EINPresswire/ -- The spray-dried biologics sector is experiencing notable expansion as the demand for more stable and efficient biologic formulations grows. This market is set ...